Comparison of the VERSANT(TM) HCV RNA qualitative assay (transcription-mediated amplification) and the COBAS AMPLICOR(TM) hepatitis C virus test, version 2.0, in patients undergoing interferon-ribavirin therapy

Author： Germer J.J.   Zein N.N.   Metwally M.A.   Hoskin T.L.   Scott Harmsen W.   Smith T.F.   Patel R.  

Publisher： Elsevier

ISSN： 0732-8893

Source： Diagnostic Microbiology and Infectious Disease, Vol.47, Iss.4, 2003-12, pp. : 615-618

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

Combination Therapy with Interferon- and Ribavirin for Hepatitis C: Practical Treatment Issues

By Collier J.   Chapman R.  

BioDrugs, Vol. 15, Iss. 4, 2001-04 ,pp. : 225-238

Adis International

Access to resources Recommend Favorite

Interferon- Alone versus Interferon- plus Ribavirin in Patients with Chronic Hepatitis C Not Responding to Previous Interferon- Treatment

By Tripi S.  

BioDrugs, Vol. 13, Iss. 4, 2000-04 ,pp. : 299-304

Adis International

Access to resources Recommend Favorite

Interferon- Therapy in Sicilian and Sardinian Polytransfused Thalassaemic Patients with Chronic Hepatitis C

By Pizzarelli G.  

BioDrugs, Vol. 12, Iss. 1, 1999-07 ,pp. : 55-63

Adis International

Access to resources Recommend Favorite

Interleukin-2 Plus Ribavirin Versus Interferon- -2b Plus Ribavirin in Patients with Chronic Hepatitis C Who Did Not Respond to Previous Interferon- -2b Treatment

By Mariano Malaguarnera  

BioDrugs, Vol. 18, Iss. 6, 2004-01 ,pp. : 407-413

Adis International

Access to resources Recommend Favorite

Good Safety Profile and Efficacy of Leucocyte Interferon- in Combination with Oral Ribavirin in Treatment-Naive Patients with Chronic Hepatitis C: A Multicentre, Randomised, Controlled Study

By Barbaro G.  

BioDrugs, Vol. 17, Iss. 6, 2003-01 ,pp. : 433-439

Adis International

Access to resources Recommend Favorite